Sinopharm Jumps Most in 5 Years on Coronavirus Vaccine Results

(Bloomberg) -- Sinopharm Group Co. surged by the most since April 2015 to lead a rally among Chinese healthcare names, as the trial results for its Covid-19 vaccine candidate rekindled investors’ e...